- Home
- SPFI vs PRME Comparison
SPFI vs PRME Comparison
Compare SPFI & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SPFI | PRME |
|---|---|---|
| Founded | 1941 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 632.4M | 666.1M |
| IPO Year | 2019 | 2022 |
Fundamental Metrics
Financial Performance| Metric | SPFI | PRME |
|---|---|---|
| Price | $41.25 | $3.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $44.00 | $7.56 |
| AVG Volume (30 Days) | 84.0K | ★ 2.5M |
| Earning Date | 04-23-2026 | 03-03-2026 |
| Dividend Yield | ★ 1.62% | N/A |
| EPS Growth | 17.81 | ★ 18.18 |
| EPS | ★ 3.44 | N/A |
| Revenue | N/A | ★ $4,632,000.00 |
| Revenue This Year | $22.65 | N/A |
| Revenue Next Year | $9.40 | N/A |
| P/E Ratio | $12.17 | ★ N/A |
| Revenue Growth | N/A | ★ 55.28 |
| 52 Week Low | $30.01 | $1.11 |
| 52 Week High | $44.00 | $6.94 |
Technical Indicators
Market Signals| Indicator | SPFI | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 49.66 | 39.33 |
| Support Level | $39.49 | $3.19 |
| Resistance Level | $41.91 | $4.74 |
| Average True Range (ATR) | 1.05 | 0.24 |
| MACD | 0.08 | -0.04 |
| Stochastic Oscillator | 62.28 | 7.32 |
Price Performance
Historical ComparisonAbout SPFI South Plains Financial Inc.
South Plains Financial Inc operates as a bank holding company. The company provides a wide range of commercial and consumer financial services to small and medium-sized businesses and individuals. The principal business activities include commercial and retail banking, along with insurance, investment, trust, and mortgage services. The company has one reportable segment: banking.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.